Klotho Neurosciences rebrands to Greenland Mines, changes ticker to GRML Mar 12, 2026 10:29AM
Klotho Neurosciences rebrands to Greenland Mines, changes ticker to GRML Mar 12, 2026 10:29AM
Klotho Neurosciences ends letter of intent with Turn Biotechnologies Oct 8, 2025 04:25AM
Klotho Neurosciences receives FDA orphan drug designation for ALS therapy Aug 18, 2025 08:31AM
Klotho Neurosciences begins manufacturing gene therapy with AAVnerGene tech Aug 12, 2025 06:00AM


Jul 24, 2025 01:30PM Klotho Neurosciences expands beyond neurology into longevity research
Jul 22, 2025 10:22AM Klotho Neurosciences partners with AAVnerGene for gene therapy manufacturing
Jul 16, 2025 06:01AM Klotho Neurosciences regains compliance with NASDAQ listing rules
Jul 10, 2025 07:20AM Klotho Neurosciences receives FDA orphan drug designation for ALS treatment
Jul 7, 2025 06:03AM Klotho Neurosciences (KLTO) Files $100M Mixed Shelf
Jun 18, 2025 07:04AM Klotho Neurosciences (KLTO) Announces Mutual Termination Of Share Exchange Agreement With Skybell Technologies (Skybell), To Continue Its Focus On Therapeutics And Longevity Programs
Jun 16, 2025 07:05AM Klotho Neurosciences (KLTO) Raises Over $11 Million, Retires All Debt, And Exceeds Nasdaq Stockholders' Equity Requirement
Oct 15, 2024 06:05AM Klotho Neurosciences (KLTO) Appoints Peter Moriarty as COO
Sep 30, 2024 06:08AM Klotho Neurosciences (KLTO) Appoints Robert Langer to its Board
Sep 17, 2024 06:31AM ANEW MEDICAL (WENA) to Rebrand as Klotho Neurosciences (KLTO)